First-in-Human Clinical Data Shows SonoTran® is Safe and Well-Tolerated
[ad_1] Data offered on the European Symposium on Ultrasound Contrast Imaging additionally demonstrated constant SonoTran® Particle activationRecruitment underway for Delivery…
Chemotherapy before surgery cuts risk of colon cancer relapse: Study | Health
[ad_1] According to the outcomes of a Cancer Research UK-funded scientific trial, giving colon most cancers sufferers chemotherapy earlier than…
Tigermed Completes Acquisition of Marti Farm
[ad_1] HANGZHOU, China and ZAGREB, Croatia, Jan. 19, 2023 /PRNewswire/ — Tigermed (300347.SZ/3347.HK), a number one international supplier of scientific…
Relief Therapeutics Announces IRB Approval of Investigator-Initiated Trial Evaluating RLF-TD011 as an Adjunctive Treatment for Cutaneous T-Cell Lymphom
[ad_1] Relief Therapeutics Holding SA / Key phrase(s): Study 17-Jan-2023 / 06:56 CET/CESTRelease of an advert hoc announcement pursuant to…
HRT ‘potentially important’ in reducing women’s dementia risk | Health
[ad_1] Hormone substitute remedy could assist forestall Alzheimer’s illness in tens of millions of ladies liable to growing the situation,…
What are privacy-enhancing technologies (PETs)?
[ad_1] As firms battle to get probably the most out of their knowledge whereas adhering to strict rules, privacy-enhancing applied…
Figur UK Reviews – Side Effects, Discount And Is It Scam?
[ad_1] The official web site of Figur sells the burden loss complement on-line. With science-backed elements, Figur offers confirmed weight…
Alzheimer’s disease: Preventive treatments may include herbal tea
[ad_1] Several research have discovered a hyperlink between the consumption of inexperienced tea and a decrease prevalence of dementia in…
Volta Medical Secures €36M in Series B Funding to Support Adoption of its AI Software for Cardiac Ablation, New CFO Introduced
[ad_1] EQS-News: Volta Medical SAS / Key phrase(s): Financing/PersonnelVolta Medical Secures €36M in Series B Funding to Support Adoption of…
Peptron’s brain disease drug candidate OKed for pediatric study in Europe < Pharma < Article
[ad_1] Peptron mentioned on Tuesday that Presendin, a drug candidate for idiopathic intracranial hypertension (IIH), collectively developed with…